HAEMATO PHARM AG is a young, expanding company which has its core focus on the trade of generics in the oncological field as well as the sales and marketing of European pharmaceuticals. Founded in 2005, we can already denote double digit yearly turn-over growth. For the year 2009, we are aiming for a yearly turn-over in the high double digit million level. Our success results from our corporate philosophy: We supply reliable, fast, highest quality at the absolute lowest price. With this attitude we have been able to establish ourselves as a successful partner in the cost-conscious pharmaceutical supply.
The core competences of HAEMATO PHARM AG are the acquisition of licenses, the production process and marketing and sales. At the moment we are in the process of enlarging our product portfolio in the therapeutic areas HIV, rheumatism, cardiovascular and life-style medicines.